PeptideStack
5.2kquestions
20kanswers
220users

How many freeze-thaw cycles will tirzepatide at 4 mg/mL tolerate?

Asked 16 Mar 2025Modified 13 months agoViewed 13k times
26

For reference: tirzepatide · 4 mg/mL.

I want a method I can write down and repeat, not a rule of thumb.

I would rather over-engineer this than discover a problem later, within reason.

Which parts of this are load-bearing and which parts are habit?

freeze-thaw
freeze-thaw

What repeated freezing does to a peptide in solution: ice-crystal shear at the growing front, freeze-concentration of solutes, pH shifts as buffer…

57 questions
peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

908 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

701 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
shareeditfollowflag
CC
askedcake_collapsed14k2716 Mar 2025

5 Answers

Accepted answer first, then by votes
84

Accepted answer

Nobody has published a cycle count, and at 4 mg/mL the concentration tells you what a wrong guess costs: a 0.1 mL aliquot holds 0.4 mg and every microlitre is 4 µg. Damage from freezing is not gradual attrition — it is concentrated at the phase transitions, where ice excludes solute and the unfrozen fraction climbs well above 4 mg/mL for as long as the transition lasts. Two slow cycles can therefore do more than four fast ones, which is why a cycle count is the wrong unit in the first place. The way to make the number one is to make it one: split at reconstitution into single-draw aliquots, label each with 4 mg/mL and the date, and never thaw a container you will refreeze.

Answer first: each freeze-thaw cycle costs something through aggregation and pH shift, so the mitigation is aliquoting rather than choosing a better freezer.

During freezing, solutes are excluded from the ice lattice and concentrate into the residual liquid. Local concentrations can rise many-fold, which promotes aggregation independently of temperature.

Degradation pathway by condition

PathwayDominant whenDetected by
DeamidationSolution, neutral to alkaline pHRP-HPLC, +1 Da on MS
OxidationLight, trace metals, peroxidesRP-HPLC, +16 Da on MS
HydrolysisSolution, extremes of pHRP-HPLC, fragment masses
AggregationAgitation, interfaces, high concentrationSEC, visual haze; often invisible on RP-HPLC
Freeze-concentration damageFreeze-thaw of buffered solutionSEC, loss of recovered content

The relevant detail is that the mitigation is aliquoting. Divide the reconstituted solution into single-use volumes before the first freeze, and each aliquot then experiences exactly one cycle.

Aliquoting to eliminate repeated cycles is standard laboratory practice for exactly this reason.

Aliquoting itself is a handling step and introduces its own contamination opportunity.

Aliquot before the first freeze. That is the whole answer.

shareimprove this answerflag
LC
answered · acceptedlyoph_cake78k26716 May 2025
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
34

The short version: aliquot before freezing, thaw slowly, never refreeze a thawed aliquot, and count your cycles.

Never refreeze a thawed aliquot. The whole point of aliquoting is that the aliquot is single-use, and refreezing it discards the benefit.

Put another way, a dry lyophilised powder is much less affected by a temperature cycle because there is no liquid phase for anything to concentrate into. Condensation on a cold vial opened warm is the real risk there.

Condensation onto cold lyophilised material on opening is a recognised handling error and is the basis for the equilibrate-before-opening rule.

Thaw slowly and never refreeze an aliquot.

shareimprove this answerflag
HN
answeredhalvard_ness69k475 May 2025
24

Concretely, this is one of the few handling questions with a genuinely quantitative literature behind it.

Let a frozen vial reach room temperature before opening it. Opening a cold vial in humid air condenses water into the cake, which raises residual moisture and undoes what lyophilisation achieved.

Thaw slowly at room temperature or in the refrigerator rather than in warm water. Rapid warming creates local thermal and concentration gradients that promote aggregation.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Dry powder tolerates cycles far better than solution does.

shareimprove this answerflag
C8
answeredcoldpack_8850k3724 Apr 2025
20

The relevant physics is ice-front concentration: as water crystallises, everything dissolved is concentrated into the shrinking liquid phase, including buffer salts.

Buffer salts crystallise at different points during freezing. Sodium phosphate is the classic example: the dibasic form crystallises first and the pH of the residual liquid falls by several units. That pH excursion is the real damage in many cases.

Count cycles, not degrees. The cycle is the damaging event.

shareimprove this answerflag
NA
answerednoor_alhassan11k2713 Apr 2025
8Adding a vote because this deserves more of them. – Dr_Tomas_Kral 4 months ago
7Does the same reasoning apply to material already in solution, or is that a different curve? – forty_two_c 2 months ago
add a comment
7

Specifically, buffer components crystallise at different rates during freezing, which shifts pH locally by a surprising amount.

Count cycles rather than worrying about degrees. Minus twenty and minus eighty differ far less than one cycle and five do.

Let a frozen vial reach room temperature before opening, or you condense water into it.

shareimprove this answerflag
SK
answereds_kalniete57k3830 Jun 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.